| 产品名称 | 吉非罗齐 |
|---|
| 英文名称 | Gemfibrozil |
|---|
| 别名 | 吉非罗齐;吉非罗齐;2,2-二甲基-5-(2,5-二甲基苯氧基)戊酸;2,2-二甲基-5-(2,5-二甲苯氧基)戊酸;5-(2,5-二甲基苯氧基)-2,2-二甲基戊酸 |
|---|
| 英文别名 | Lopid; CI-719;2,2-Dimethyl-5-(2,5-dimethylphenoxy)pentanoic Acid;2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeric Acid;5-(2,5-Dimethylphenoxy)-2,2-dimethylpentanoic aci |
|---|
| 应用 | A hyperlipidemic agent. |
|---|
| 规格或纯度 | ≥99% |
|---|
| 运输条件 | 常规运输 |
|---|
| 生化机理 | Gemfibrozil is a hyperlipidemic agent that elevates plasma HDL and lowers triglycerides and LDL by stabilizing apoA-I mRNA transcripts. It was found to inhibit inducible nitric oxide synthase by inhibiting the activation of nuclear factor-kappaB, activator protein-1 and CCAAT/enhancer-binding protein β.PPARα activator. Increases the expression of PPAR-β but not PPAR-γ. Shows lipid-lowering and anti-inflammatory effects in vivo . Orally active. |
|---|